Iaroslava Kos

Iaroslava Kos has a strong background in business development and research in the life sciences field. Iaroslava began their career as a Researcher at INRA, where they contributed to a project focused on understanding the virulence determinants of the fungal pathogen Candida albicans. After this, they joined Bienta, a division of Enamine Ltd., as a Business Development Manager. In this role, they helped provide preclinical biology services for drug discovery research. Iaroslava later transitioned to Enamine Ltd. as the Director of Business Development, where their main responsibility is to uncover new opportunities and convert them into leads. Throughout their career, Iaroslava has demonstrated a dedication to the drug discovery and development area, combining their expertise in biology and chemistry.

Iaroslava Kos began their education journey by completing their high school education in biology and chemistry at Ivan Franko National University of Lviv from 2003 to 2005. Iaroslava then pursued their undergraduate studies at the same university, earning a M.Sc. degree in biology with a focus on genetics from 2005 to 2010. Afterward, they enrolled in Newcastle University, where they pursued a Doctor of Philosophy (Ph.D.) degree in Biomedical Sciences from 2013 to 2016. During their Ph.D. studies, Iaroslava had the opportunity to participate in a secondment at Institut Pasteur in 2015, further enhancing their knowledge and expertise in the field of biomedical sciences.